Holter Versus Zio Patch Electrocardiographic Monitoring in Children
Comparison of Holter With Leadless Patch Ambulatory Electrocardiographic Monitoring in Children
1 other identifier
interventional
247
1 country
1
Brief Summary
This prospective study aims to compare the diagnostic yield, or ability to detect an arrhythmia, of the traditional Holter monitor versus the novel Zio patch monitor in pediatric patients referred for ambulatory electrocardiographic (ECG) monitoring. Children will wear both devices simultaneously for 48 hours and the incidence of clinically significant arrhythmias will be compared.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 5, 2017
CompletedFirst Posted
Study publicly available on registry
October 16, 2017
CompletedStudy Start
First participant enrolled
October 18, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 19, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 19, 2019
CompletedResults Posted
Study results publicly available
June 18, 2024
CompletedJune 18, 2024
May 1, 2024
2 years
October 5, 2017
September 20, 2021
May 22, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Participants With Difference in Detection of Clinically Significant Arrhythmias for the Zio Versus the Holter
The diagnostic yield, or the ability to detect an arrhythmia, will be measured for the Holter monitor and the Zio patch monitor for each patient. The diagnostic yield for each arrhythmia subtype will be determined for each device across all patients and compared in paired statistical analysis (McNemar's test).
48 hours
Secondary Outcomes (1)
Prevalence of Artifact Detected
48 hours
Other Outcomes (1)
Percentage of Patients Who Preferred the Zio Over the Holter
48 hours
Study Arms (1)
Holter Monitor and Zio Patch
OTHERAll subjects will wear the Holter monitor and Zio patch for a total of 48 hours.
Interventions
A Holter monitor is a battery-operated portable device that measures and records your heart's electrical activity (ECG) continuously. Patients in this study will wear the monitor for 48 hours.
The Zio Patch is a small, adhesive, water-resistant single lead electrocardiographic monitoring device. Patients in this study will wear the patch for 48 hours.
Eligibility Criteria
You may qualify if:
- Any patient under age 22 years who has been referred for ambulatory ECG monitoring at Children's Hospital of New York.
You may not qualify if:
- Any known skin allergy or sensitivity to adhesive material.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Columbia University Medical Center
New York, New York, 10032, United States
Related Publications (8)
Barrett PM, Komatireddy R, Haaser S, Topol S, Sheard J, Encinas J, Fought AJ, Topol EJ. Comparison of 24-hour Holter monitoring with 14-day novel adhesive patch electrocardiographic monitoring. Am J Med. 2014 Jan;127(1):95.e11-7. doi: 10.1016/j.amjmed.2013.10.003. Epub 2013 Oct 15.
PMID: 24384108BACKGROUNDBolourchi M, Batra AS. Diagnostic yield of patch ambulatory electrocardiogram monitoring in children (from a national registry). Am J Cardiol. 2015 Mar 1;115(5):630-4. doi: 10.1016/j.amjcard.2014.12.014. Epub 2014 Dec 18.
PMID: 25591894BACKGROUNDCheung CC, Kerr CR, Krahn AD. Comparing 14-day adhesive patch with 24-h Holter monitoring. Future Cardiol. 2014 May;10(3):319-22. doi: 10.2217/fca.14.24.
PMID: 24976467BACKGROUNDLobodzinski SS. ECG patch monitors for assessment of cardiac rhythm abnormalities. Prog Cardiovasc Dis. 2013 Sep-Oct;56(2):224-9. doi: 10.1016/j.pcad.2013.08.006.
PMID: 24215754BACKGROUNDRosenberg MA, Samuel M, Thosani A, Zimetbaum PJ. Use of a noninvasive continuous monitoring device in the management of atrial fibrillation: a pilot study. Pacing Clin Electrophysiol. 2013 Mar;36(3):328-33. doi: 10.1111/pace.12053. Epub 2012 Dec 13.
PMID: 23240827BACKGROUNDSchreiber D, Sattar A, Drigalla D, Higgins S. Ambulatory cardiac monitoring for discharged emergency department patients with possible cardiac arrhythmias. West J Emerg Med. 2014 Mar;15(2):194-8. doi: 10.5811/westjem.2013.11.18973.
PMID: 24672611BACKGROUNDTung CE, Su D, Turakhia MP, Lansberg MG. Diagnostic Yield of Extended Cardiac Patch Monitoring in Patients with Stroke or TIA. Front Neurol. 2015 Jan 12;5:266. doi: 10.3389/fneur.2014.00266. eCollection 2014.
PMID: 25628595BACKGROUNDTurakhia MP, Hoang DD, Zimetbaum P, Miller JD, Froelicher VF, Kumar UN, Xu X, Yang F, Heidenreich PA. Diagnostic utility of a novel leadless arrhythmia monitoring device. Am J Cardiol. 2013 Aug 15;112(4):520-4. doi: 10.1016/j.amjcard.2013.04.017. Epub 2013 May 11.
PMID: 23672988BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Leonardo Liberman, MD
- Organization
- Columbia University
Study Officials
- PRINCIPAL INVESTIGATOR
Leonardo Liberman, MD
Columbia University
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 5, 2017
First Posted
October 16, 2017
Study Start
October 18, 2017
Primary Completion
October 19, 2019
Study Completion
October 19, 2019
Last Updated
June 18, 2024
Results First Posted
June 18, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share